|本期目录/Table of Contents|

[1]刘广宇,吴焕焕,白人驹.MRI平扫在肾脏嗜酸细胞瘤与嫌色细胞癌鉴别诊断中的价值[J].天津医科大学学报,2021,27(04):405-408.
 LIU Guang-yu,WU Huan-huan,BAI Ren-ju.The value of MRI plain scan in the differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma[J].Journal of Tianjin Medical University,2021,27(04):405-408.
点击复制

MRI平扫在肾脏嗜酸细胞瘤与嫌色细胞癌鉴别诊断中的价值(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
27卷
期数:
2021年04期
页码:
405-408
栏目:
临床医学
出版日期:
2021-07-20

文章信息/Info

Title:
The value of MRI plain scan in the differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma
文章编号:
1006-8147(2021)04-0405-04
作者:
刘广宇吴焕焕白人驹
(天津医科大学总医院医学影像科,天津 300052)
Author(s):
LIU Guang-yuWU Huan-huanBAI Ren-ju
(Department of Radiology,General Hospital,Tianjin Medical University,Tianjin 300052,China)
关键词:
嗜酸细胞瘤嫌色细胞癌核磁共振扩散加权成像表观扩散系数标准化信号强度
Keywords:
headspace gas chromatographyorganic solventwhole blood
分类号:
R781.4
DOI:
-
文献标志码:
A
摘要:
目的:评估MRI平扫量化参数在肾脏嗜酸细胞瘤与嫌色细胞癌鉴别诊断中的价值。方法:本研究回顾性分析42例经病理证实患者的MRI平扫数据,其中嗜酸细胞瘤18例,嫌色细胞癌24例。由两名医生采用盲法测量肿瘤实性成分的T1WI及T2WI标准化信号值(SSI)、表观弥散系数(ADC)。应用组内相关系数(ICC)评估测量的可靠性,采用独立样本t检验分析各参数间差异的统计学意义,受试者工作特性(ROC)曲线分析来衡量各参数的诊断效能。结果:两名医师的测量具有极高的可靠性(ICC:0.805~0.911)。嫌色细胞癌的平均ADC值低于嗜酸细胞瘤[(1.07±0.20)×10-3 mm2/s vs.(1.48±0.17)×10-3 mm2/s;P<0.001],T2WI-SSI高于嗜酸细胞瘤[(1.72±0.22)vs.(1.32±0.26);P<0.001],T1WI-SSI在两组间差异无显著意义[(0.89±0.15)vs.(0.80±0.12);P=0.35]。ROC分析显示ADC值的曲线下面积(AUC)高于T2WI-SSI(0.942 vs. 0.859)。结论:ADC值与T2WI标准化信号强度对于鉴别肾嗜酸细胞瘤和嫌色细胞癌均有帮助,但ADC值具有更高的诊断价值。
Abstract:
Objective: To evaluate the value of quantitative parameters of MRI plain scan sequence on distinguishing renal oncocytoma from chromophobe cell carcinoma. Methods: The MRI plain scan imaging of 42 patients were retrospectively evaluated. All cases were pathologically diagnosed after operation,including 18 renal oncocytoma and 24 chromophobe renal cell carcinoma. Two radiologists blindly measured the standardized signal intensity(SSI) of T1WI and T2WI,apparent diffusion coefficient(ADC) values of the solid components in the tumor. The intraclass correlation coefficient(ICC) was calculated to analyze the reliability of the measurements. The independent sample t-test was used to analyze the statistical significance of the differences between the parameters,and receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic performance of each parameter. Results: The ICC value of the two radiologists ranged from 0.805 to 0.911,indicating highly reliable measurement. The mean ADC value of chromophobe cell carcinoma was lower than that of renal oncocytoma[(1.07±0.20)×10-3 mm2/s vs.(1.48±0.17)×10-3 mm2/s;P<0.001],and the mean T2WI-SSI was higher than that of renal oncocytoma[(1.72±0.22) vs.(1.32±0.26),P<0.001],while there was no significant difference in T1WI-SSI between renal oncocytoma and chromophobe renal cell carcinoma[(0.89±0.15) vs. (0.80±0.12);P=0.35]. ROC analysis showed that the area under curve (AUC) of ADC value were higher than that of T2WI-SSI(0.942 vs. 0.859). Conclusion: Both ADC value and T2WI-SSI are helpful for differentiating renal oncocytoma from chromophobe renal cell carcinoma,with ADC showing higher diagnostic value.

参考文献/References:

[1] Amin M B,Crotty T B,Tickoo S K,et al. Renal oncocytoma:a reappraisal of morphologic features with clinicopathologic findings in 80 cases[J]. Am J Surg Pathol,1997,21(1):1
[2] 孔晓静,王海屹,叶慧义. CT动态增强扫描鉴别肾嫌色细胞癌与肾嗜酸细胞瘤的价值[J].中国医学影像学杂志,2013,21(10):761
[3] Moch H,Cubilla A L,Humphrey P A,et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A:renal,penile,and testicular tumours[J]. Eur Urol,2016,70(1):93
[4] Ljungberg B,Bensalah K,Canfield S,et al. EAU guidelines on renal cell carcinoma:2014 update[J]. Eur Urol,2015,67(5):913
[5] Ishigami K,Jones A R,Dahmoush L,et al. Imaging spectrum of renal oncocytomas:a pictorial review with pathologic correlation[J]. Insights Imaging,2015,6(1):53
[6] Wobker S E,Przybycin C G,Sircar K,et al. Renal oncocytoma with vascular invasion:a series of 22 cases[J]. Hum Pathol,2016,58(58):1
[7] Pedrosa I,Sun M R,Spencer M,et al.MR imaging of renal masses: correlation with findings at surgery and pathologic analysis[J]. Radiographics,2008,28(4):985
[8] Goyal A,Sharma R,Bhalla A S,et al. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype[J]. Acta Radiol,2012,53(3):349
[9] Vargas H A,Chaim J,Lefkowitz R A,et al. Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes[J]. Radiology,2012,264(3):779
[10] Sun M R,Ngo L,Genega E M,et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings[J].Radiology,2009,250(3):793
[11] Koh D M,Collins D J. Diffusion-weighted MRI in the body: applications and challenges in oncology[J]. AJR Am J Roentgenol,2007, 188(6):1622
[12] Padhani A R,Liu G,Koh D M,et al.Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations[J]. Neoplasia,2009,11(2):102
[13] Lassel E A,Rao R,Schwenke C,et al. Diffusion-weighted imaging of focal renal lesions: a meta-analysis[J]. Eur Radiol,2014,24(1):241
[14] Taouli B,Thakur R K,Mannelli L,et al. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging[J]. Radiology,2009,251(2):398
[15] Razek A A,Farouk A,Mousa A,et al. Role of diffusion-weighted magnetic resonance imaging in characterization of renal tumors[J]. J Comput Assist Tomogr,2011,35(3):332
[16] G?觟ya C,Hamidi C,Bozkurt Y,et al. The role of apparent diffusion coefficient quantification in differentiating benign and malignant renal masses by 3 tesla magnetic resonance imaging[J]. Balkan Med J,2015,32(3):273
[17] Lei Y,Wang H,Li H F,et al. Diagnostic significance of diffusion-weighted MRI in renal cancer[J]. Biomed Res Int,2015:172165
[18] Sandrasegaran K,Sundaram C P,Ramaswamy R,et al. Usefulness of diffusion-weighted imaging in the evaluation of renal masses[J]. Am J Roentgenol,2010,194(2):438
[19] LeBihan D. Intravoxel incoherent motion imaging using steady-state free precession[J]. Magn Reson Med,1988,7(3):346
[20] Zhong Y,Wang H,Shen Y,et al. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas[J]. Eur Radiol,2017,27(12):4913
[21] Sevcenco S,Heinz-Peer G,Ponhold L,et al. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors[J]. Eur J Radiol,2014,83(6):909
[22] Mirka H,Korcakova E,Kastner J,et al. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors[J]. Anticancer Res,2015,35(4):2351

相似文献/References:

[1]王 奇,张昌文,张志宏.肾上腺皮质嗜酸细胞瘤1例报告[J].天津医科大学学报,2018,24(01):23.

备注/Memo

备注/Memo:
作者简介:刘广宇(1975-),男,主治医师,学士,研究方向:腹盆部影像诊断;通信作者:白人驹,E-mail:cjr.bairenju@vip.163.com。
MRI平扫在肾脏嗜酸细胞瘤与嫌色细胞癌鉴别诊断中的价值
更新日期/Last Update: 2021-07-25